tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ASRT Stock Latest News

Assertio regains compliance with Nasdaq listing requirements
The FlyAssertio regains compliance with Nasdaq listing requirements
25d ago
ASRT
Assertio price target adjusted to $35 from $3 at H.C. Wainwright
PremiumThe Fly
Assertio price target adjusted to $35 from $3 at H.C. Wainwright
1M ago
ASRT
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/31/25
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/31/25
1M ago
EB
VTI
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/30/25
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/30/25
1M ago
EB
VTI
Vanguard Total Stock Market ETF (VTI) Daily Update—12/29/25
PremiumMarket News
Vanguard Total Stock Market ETF (VTI) Daily Update—12/29/25
1M ago
EB
VTI
Assertio Therapeutics trading halted, news pending
PremiumThe FlyAssertio Therapeutics trading halted, news pending
1M ago
ASRT
Assertio Therapeutics Announces 1-for-15 Reverse Stock Split
Premium
Company Announcements
Assertio Therapeutics Announces 1-for-15 Reverse Stock Split
2M ago
8K
ASRT
Assertio announces one-for-fifteen reverse stock split
Premium
The Fly
Assertio announces one-for-fifteen reverse stock split
2M ago
ASRT
Assertio Therapeutics Announces Leadership Change with CEO Resignation
PremiumCompany Announcements
Assertio Therapeutics Announces Leadership Change with CEO Resignation
3M ago
8K
ASRT
Assertio Therapeutics: Strategic Moves and Leadership Changes Drive Buy Rating
PremiumRatings
Assertio Therapeutics: Strategic Moves and Leadership Changes Drive Buy Rating
3M ago
ASRT
Assertio Therapeutics Reports Strong Q3 Earnings Amid Rolvedon Growth
PremiumCompany Announcements
Assertio Therapeutics Reports Strong Q3 Earnings Amid Rolvedon Growth
3M ago
ASRT
Assertio Therapeutics Reports Strong Q3 2025 Results
PremiumCompany Announcements
Assertio Therapeutics Reports Strong Q3 2025 Results
3M ago
ASRT
Assertio Therapeutics Promotes Paul Schwichtenberg to President
PremiumCompany AnnouncementsAssertio Therapeutics Promotes Paul Schwichtenberg to President
3M ago
8K
ASRT
Assertio narrows FY25 product sales view to $110M-$112M from $108M-$118M
Premium
The Fly
Assertio narrows FY25 product sales view to $110M-$112M from $108M-$118M
3M ago
ASRT
Assertio names Paul Schwichtenberg president, COO
Premium
The Fly
Assertio names Paul Schwichtenberg president, COO
3M ago
ASRT
Assertio reports Q3 EPS 11c vs (3c) last year
PremiumThe Fly
Assertio reports Q3 EPS 11c vs (3c) last year
3M ago
ASRT
Is ASRT a Buy, Before Earnings?
PremiumPre-Earnings
Is ASRT a Buy, Before Earnings?
3M ago
ASRT
Assertio Therapeutics Announces New CEO Appointment
PremiumCompany Announcements
Assertio Therapeutics Announces New CEO Appointment
3M ago
8K
ASRT
Assertio CEO Brendan O’Grady to depart, Mark Reisenauer to succeed
PremiumThe Fly
Assertio CEO Brendan O’Grady to depart, Mark Reisenauer to succeed
3M ago
ASRT
Assertio Therapeutics Amends ROLVEDON Supply Agreement
PremiumCompany AnnouncementsAssertio Therapeutics Amends ROLVEDON Supply Agreement
4M ago
8K
ASRT
Assertio Therapeutics’ Growth Potential Driven by Sympazan and Stable Revenue Streams
Premium
Ratings
Assertio Therapeutics’ Growth Potential Driven by Sympazan and Stable Revenue Streams
5M ago
ASRT
Buy Rating Affirmed for Assertio Therapeutics Amid Positive Sympazan Study and Strong Financial Outlook
Premium
Ratings
Buy Rating Affirmed for Assertio Therapeutics Amid Positive Sympazan Study and Strong Financial Outlook
5M ago
ASRT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >